Bio-techne Corp. Earnings

Bio-techne Corp.’s revenue fell -0.39% since last year same period to $295.88Mn in the Q4 2025. On a quarterly growth basis, Bio-techne Corp. has generated 3.25% jump in its revenue since last 3-months.

Bio-techne Corp.’s net profit jumped 8.94% since last year same period to $38.01Mn in the Q4 2025. On a quarterly growth basis, Bio-techne Corp. has generated -0.46% fall in its net profits since last 3-months.

Bio-techne Corp.’s net profit margin jumped 9.36% since last year same period to 12.85% in the Q4 2025. On a quarterly growth basis, Bio-techne Corp. has generated -3.6% fall in its net profit margins since last 3-months.

Bio-techne Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.54 - a 25.84% jump from last quarter’s estimates.

Bio-techne Corp.’s earning per share (EPS) estimates for the current year stand at 0.54.

Bio-techne Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Bio-techne Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Bio-techne Corp. declared 0.08 dividend per share during the earnings announcement for Q1 2026.